Showing results 1 to 20 of 54
next >
| Rights | Preview | Issue Date | Title | Author(s) | Type |
| closedAccess |  | 2005 | Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin | Yuste, Laura CSIC; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2012 | Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer | Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID CVN ; Re-Louhau, M. F. CSIC; Seoane, Samuel CSIC ORCID; Abad, María del Mar; Calero, R.; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 30-Aug-2019 | Activity of BET-proteolysis targeting chimeric (PROTAC) compounds in triple negative breast cancer | Noblejas-López, María del Mar; Nieto-Jiménez, Cristina; Burgos, Miguel; Gómez-Juárez, Mónica; Montero, Juan Carlos CSIC ORCID; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Alberto | artículo |
| openAccess |  | 2021 | Altered proTGFα/cleaved TGFα ratios offer new therapeutic strategies in renal carcinoma | García-Alonso, Sara; Romero-Pérez, Inés; Gandullo-Sánchez, Lucía CSIC ORCID; Chinchilla, Luis; Ocaña, Alberto; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2015 | Antitumor activity of the novel multi-kinase inhibitor EC-70124 in triple negative breast cancer | Cuenca-López, María D.; Serrano-Heras, Gemma CSIC ORCID; Montero, Juan Carlos CSIC ORCID; Morales, Jorge C.; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
| openAccess |  | 2015 | Antitumoral activity of the mithralog EC-8042 in triple negative breast cancer linked to cell cycle arrest in G2 | Pandiella, Atanasio CSIC ORCID CVN ; Morís, Francisco; Ocaña, Alberto; Núñez, Luz-Elena; Montero, Juan Carlos CSIC ORCID | artículo |
| closedAccess |  | 2008 | Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo | Mitsiades, C. S.; Ocio, Enrique M. CSIC ORCID ; Pandiella, Atanasio CSIC ORCID CVN ; Maiso, Patricia; Gajate, Consuelo CSIC ORCID ; Garayoa, Mercedes CSIC ORCID ; Vilanova, David; Montero, Juan Carlos CSIC ORCID; Mollinedo, Faustino CSIC ORCID ; San Miguel, Jesús F. CSIC ORCID | artículo |
| closedAccess |  | 2016 | Breast cancer dissemination promoted by a neuregulin-collagenase 3 signalling node | Seoane, Samuel CSIC ORCID; Montero, Juan Carlos CSIC ORCID; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2021 | Checkpoint Kinase 1 Pharmacological Inhibition Synergizes with DNA-Damaging Agents and Overcomes Platinum Resistance in Basal-Like Breast Cancer | Nieto-Jiménez, Cristina; Alcaraz-Sanabria, Ana; Martínez-Canales, Sandra; Corrales-Sánchez, Verónica; Montero, Juan Carlos CSIC ORCID; Burgos, Miguel; Nuncia-Cantarero, Miriam; Pandiella, Atanasio CSIC ORCID CVN ; Galán-Moya, Eva María; Ocaña, Alberto | artículo |
| closedAccess |  | 1999 | Cleavage of the TrkA neurotrophin receptor by multiple metalloproteases generates signalling-competent truncated forms | Díaz-Rodríguez, Elena CSIC ORCID CVN; Cabrera, Noemí CSIC; Esparís-Ogando, Azucena CSIC ORCID CVN ; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 2017 | CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia | Guerra, Borja CSIC ORCID; Martín-Rodríguez, Patricia CSIC; Díaz-Chico, Juan Carlos; McNaughton-Smith, Grant; Jiménez-Alonso, Sandra; Hueso-Falcón, Idaira; Montero, Juan Carlos CSIC ORCID; Blanco, Rosa CSIC; León, Javier CSIC ORCID CVN; Rodríguez-González, Germán; Estévez-Braun, Ana; Pandiella, Atanasio CSIC ORCID CVN ; Díaz-Chico, Bonifacio Nicolás; Fernández-Pérez, Leandro CSIC ORCID | artículo |
| closedAccess |  | 2000 | Differential shedding of transmembrane neuregulin isoforms by the tumor necrosis factor-α-converting enzyme | Montero, Juan Carlos CSIC ORCID; Yuste, Laura CSIC; Díaz-Rodríguez, Elena CSIC ORCID CVN; Esparís-Ogando, Azucena CSIC ORCID CVN ; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 22-Sep-2010 | Effect of multikinase inhibitors on caspase-independent cell death and DNA damage in HER2-overexpressing breast cancer cells | Seoane, Samuel CSIC ORCID; Montero, Juan Carlos CSIC ORCID; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2019 | Efficacy and safety of dasatinib with trastuzumab and paclitaxel in first line HER2-positive metastatic breast cancer: results from the phase II GEICAM/2010-04 study | Ocaña, Alberto; Gil-Martín, Marta; Antolín, Silvia; Atienza, María; Montaño, Álvaro; Ribelles, Nuria; Urruticoechea, Ander; Falcón, Alejandro; Pernas, Sonia; Orlando, Javier; Montero, Juan Carlos CSIC ORCID; Escudero, María José; Benito, Sara; Caballero, Rosalía; Carrasco, Eva; Rojo, Federico; Pandiella, Atanasio CSIC ORCID CVN ; Ruiz-Borrego, Manuel | artículo |
| closedAccess |  | 1-Apr-2010 | Enhancement of Antiproliferative Activity by Molecular Simplification of Catalpol | García, Celina; León, Leticia G; Pungitore, Carlos R.; Ríos-Luci, Carla; Hernández Daranas, Antonio CSIC ORCID ; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN ; Tonn, Carlos E.; Martín, Víctor S.; Padrón, José M. | artículo |
| closedAccess |  | 2007 | Erk5 is activated and acts as a survival factor in mitosis | Gírio, Ana; Montero, Juan Carlos CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | Jan-2002 | Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2 | Esparís-Ogando, Azucena CSIC ORCID CVN ; Díaz-Rodríguez, Elena CSIC ORCID CVN; Montero, Juan Carlos CSIC ORCID; Yuste, Laura CSIC; Crespo, Piero CSIC ORCID; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| openAccess |  | 15-May-2009 | Expression of Erk5 in early stage breast cancer and association with disease free survival identifies this kinase as a potential therapeutic target | Montero, Juan Carlos CSIC ORCID; Ocaña, Alberto; Abad, María del Mar; Ortiz-Ruiz, María Jesús CSIC; Pandiella, Atanasio CSIC ORCID CVN ; Esparís-Ogando, Azucena CSIC ORCID CVN | artículo |
| openAccess |  | 2015 | Identification of therapeutic targets in ovarian cancer through active tyrosine kinase profiling | Montero, Juan Carlos CSIC ORCID; García-Alonso, Sara; Ocaña, Alberto; Pandiella, Atanasio CSIC ORCID CVN | artículo |
| closedAccess |  | 2016 | In silico analysis guides selection of BET Inhibitors for triple-negative breast cancer treatment | Pérez-Peña, Javier; Serrano-Heras, Gemma CSIC ORCID; Montero, Juan Carlos CSIC ORCID; Corrales-Sánchez, Verónica; Pandiella, Atanasio CSIC ORCID CVN ; Ocaña, Alberto | artículo |
